成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 50998-17-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 50998-17-9
Chemical Structure| 50998-17-9
Structure of 50998-17-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 50998-17-9 ]

Related Doc. of [ 50998-17-9 ]

Alternatived Products of [ 50998-17-9 ]
Product Citations

Product Details of [ 50998-17-9 ]

CAS No. :50998-17-9 MDL No. :MFCD00837757
Formula : C8H5BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :NOYFLUFQGFNMRB-UHFFFAOYSA-N
M.W : 209.04 Pubchem ID :610939
Synonyms :

Calculated chemistry of [ 50998-17-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.24
TPSA : 25.78 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.87
Log Po/w (XLOGP3) : 2.27
Log Po/w (WLOGP) : 2.39
Log Po/w (MLOGP) : 1.61
Log Po/w (SILICOS-IT) : 2.65
Consensus Log Po/w : 2.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.24
Solubility : 0.121 mg/ml ; 0.000577 mol/l
Class : Soluble
Log S (Ali) : -2.45
Solubility : 0.745 mg/ml ; 0.00356 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.19
Solubility : 0.0136 mg/ml ; 0.0000652 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.63

Safety of [ 50998-17-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 50998-17-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50998-17-9 ]
  • Downstream synthetic route of [ 50998-17-9 ]

[ 50998-17-9 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 50998-17-9 ]
  • [ 97674-02-7 ]
  • [ 83570-42-7 ]
Reference： [1] Patent: US2005/256309, 2005, A1, . Location in patent: Page/Page column 35
[2] Patent: US2005/272736, 2005, A1, . Location in patent: Page/Page column 35
[3] Patent: WO2016/30443, 2016, A1, . Location in patent: Page/Page column 80
[4] Patent: WO2017/144633, 2017, A1, . Location in patent: Page/Page column 95
[5] Patent: WO2017/144639, 2017, A1, . Location in patent: Page/Page column 80
  • 2
  • [ 50998-17-9 ]
  • [ 83570-42-7 ]
YieldReaction ConditionsOperation in experiment
45% With bis-triphenylphosphine-palladium(II) chloride In toluene at 20 - 90℃; To a degassed stirred solution of 6-bromo quinoxaline (2.0 g, 9.50 mmol) in toluene (20 mL), 1- ethoxy vinyl tributyltin (3.8 g, 10.5 mmol) followed by Pd(PPh3)2CI2 (0.67 g, 0.95 mmol) were added at RT and stirred at 90 °C overnight. After completion of the reaction (monitored by TLC), the reaction mixture was cooled to RT, filtered through celite and the obtained filtrate was evaporated under vacuum. To the resulting crude mixture, 6 N HCI solution (20 mL) was added and the mixture was stirred at RT for 1 h. The solution was neutralized with sat. NaHC03 and the aqueous layer was extracted with DCM (2 x 100 mL). The combined organic layer was dried over Na2S04 and concentrated under vacuum. The resulting crude material was purified by flash chromatography (Biotage Isolera, eluent: 30percent EtOAc in hexane) to afford the title compound. Yield: 45percent (800 mg, brown solid). 1H NMR (400 MHz, DMSO-tf6): δ 9.06-9.04 (m, 2H), 8.70 (d, J = 2.4 Hz, 1 H), 8.28 (dd, J = 8.8, 2.8 Hz, 1 H), 8.16 (d, J = 8.4 Hz, 1 H), 2.97 (s, 3H). LCMS: (Method A) 173 (M+H), Rt. 2.2 min, 99.1 percent (Max).
Reference： [1] Patent: WO2019/37860, 2019, A1, . Location in patent: Page/Page column 68
  • 3
  • [ 3476-89-9 ]
  • [ 91-19-0 ]
  • [ 50998-17-9 ]
  • [ 76982-23-5 ]
YieldReaction ConditionsOperation in experiment
35% With bromine In acetonitrile for 2.5 h; Reflux; Inert atmosphere General procedure: Bromine was added dropwise to a magnetically stirred refluxing solution of quinoxaline (1) or tetrahydroquinoxaline 15 or 19 in the relevant solvent. The resulting reaction mixture was heated at reflux temperature. The reaction was monitored by TLC or 1H NMR spectroscopy. After the desired time, the resulting reaction mixture was allowed to cool to room temperature and the solvent was removed under reduced pressure. The mixture was diluted with a saturated solution of sodium carbonate (10mL) and the mixture was extracted with ethyl acetate (2×25mL). Combined organic layers were washed with water, dried over Na2SO4 and concentrated. The crude was purified appropriate method described in below.
Reference： [1] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
  • 4
  • [ 34413-35-9 ]
  • [ 50998-17-9 ]
  • [ 76982-23-5 ]
Reference： [1] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
[2] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
  • 5
  • [ 2423-66-7 ]
  • [ 50998-17-9 ]
  • [ 76982-23-5 ]
Reference： [1] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
[2] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
  • 6
  • [ 528852-07-5 ]
  • [ 50998-17-9 ]
  • [ 76982-23-5 ]
Reference： [1] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
  • 7
  • [ 91-19-0 ]
  • [ 50998-17-9 ]
  • [ 76982-23-5 ]
Reference： [1] Tetrahedron, 2017, vol. 73, # 12, p. 1618 - 1632
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 50998-17-9 ]

Bromides

Chemical Structure| 76982-23-5

[ 76982-23-5 ]

5-Bromoquinoxaline

Similarity: 0.92

Chemical Structure| 50358-63-9

[ 50358-63-9 ]

6-Amino-5-bromoquinoxaline

Similarity: 0.85

Chemical Structure| 212327-11-2

[ 212327-11-2 ]

7-Bromoquinoxalin-2-amine

Similarity: 0.85

Chemical Structure| 55687-02-0

[ 55687-02-0 ]

6-Bromo-2-chloroquinoxaline

Similarity: 0.81

Chemical Structure| 55687-34-8

[ 55687-34-8 ]

6-Bromoquinoxalin-2(1H)-one

Similarity: 0.81

Related Parent Nucleus of
[ 50998-17-9 ]

Quinoxalines

Chemical Structure| 76982-23-5

[ 76982-23-5 ]

5-Bromoquinoxaline

Similarity: 0.92

Chemical Structure| 50358-63-9

[ 50358-63-9 ]

6-Amino-5-bromoquinoxaline

Similarity: 0.85

Chemical Structure| 212327-11-2

[ 212327-11-2 ]

7-Bromoquinoxalin-2-amine

Similarity: 0.85

Chemical Structure| 55687-02-0

[ 55687-02-0 ]

6-Bromo-2-chloroquinoxaline

Similarity: 0.81

Chemical Structure| 55687-34-8

[ 55687-34-8 ]

6-Bromoquinoxalin-2(1H)-one

Similarity: 0.81

; ;